REduction of Contrast Via DyeVert Used in CTO Procedures

Stopped early

Conditions studied: Chronic Total Occlusion of Coronary Artery

In brief

The is an observational, prospective study to evaluate the effect of the DyeVert System on contrast volume administration in patients undergoing clinically-indicated chronic total occlusion (CTO) percutaneous coronary intervention (PCI)

Key facts

Study ID

NCT03118544

Run by

Minneapolis Heart Institute Foundation

People needed

21

Starts

2017-03-26

Expected to finish

2018-02-02

Last updated by the study team

2018-05-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects undergoing CTO PCI at each of the participating centers.
• Contrast volume recorded during CTO PCI
• Subjects included in the "Multicenter Registry of Chronic Total Occlusion Interventions" study (Allina IRB approval # 948134-1)

You may not qualify if…

• None

Where it is running

• Abbott Northwestern Hospital — Minneapolis, Minnesota, United States
• Minneapolis Heart Institute Foundation — Minneapolis, Minnesota, United States
• Minneapolis Heart Institute — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.